Delivery Order SPE2DE24D0013-SPE2D625F8XH9
- Not listed
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $20.4K to Cepheid Inc. on July 25, 2025, for molecular diagnostic solutions. Designated as Contract Number 4568895371 with the identifier XPCOV2/FLU/RSV-10, this firm fixed-price delivery order is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostics testing solutions, specifically targeting...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,104 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award builds upon Cepheid's extensive track record providing molecular diagnostic...
- The Defense Department's Medical Supply Chain awarded a $2,395.95 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on July 21, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation and represents a procurement under the company's existing indefinite delivery vehicle contracts with the Veterans Health Administration. Cepheid specializes in GeneXpert...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $2,208 firm fixed-price delivery order to Cepheid Inc. for a molecular diagnostic kit (KIT XPERT XPRESS STRP GRP A MOL BIO) on July 23, 2025, with an ultimate completion date of July 30, 2025. This delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a continuation of the federal government's reliance on Cepheid's specialized...
- The U.S. Defense agency's Medical Supply Chain issued a delivery order valued at $4,901.39 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract number GXCT/NG-10. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid specializes in providing advanced molecular...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on July 28, 2025, for molecular diagnostic testing solutions. This firm fixed-price delivery order, designated 4568920464 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 11, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8XH9Delivery Order
The U.S. Defense department's Medical Supply Chain agency awarded a delivery order valued at $1,440 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on July 28, 2025. This firm fixed-price delivery order, designated as 4568910320 and issued under the GXCDIFF/EPI-10 vehicle, carries an ultimate completion date of August 4, 2025, with no set-aside designation. The award represents a continuation of the federal government's procurement of Cepheid's advanced diagnostic solutions, which the company specializes in developing and delivering across multiple federal healthcare systems. Cepheid maintains a substantial presence in the federal molecular diagnostics market through two significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, valued at $32.8 million and $2.5 million respectively, which enable ongoing procurement of diagnostic testing systems, reagents, and assays. The company's product portfolio includes GeneXpert diagnostic systems and molecular testing capabilities designed to detect infectious diseases including COVID-19, influenza, respiratory syncytial virus, Methicillin-resistant Staphylococcus aureus, and other clinical conditions. This delivery order under the Medical Supply Chain agency continues Cepheid's established role as a primary provider of molecular diagnostic solutions to defense and federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/28/25 |